South Korea Pharmaceuticals Market Summary, Competitive Analysis and Forecast to 2027

Pharmaceuticals in South Korea industry profile provides top-line qualitative and quantitative summary information including: market size (value 2017-22, and forecast to 2027). The profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market.

Key Highlights

The pharmaceuticals market consists of ethical drugs only and does not include consumer healthcare or animal healthcare.
The South Korean pharmaceuticals market had total revenues of $30.6 billion in 2022, representing a compound annual growth rate (CAGR) of 5.2% between 2017 and 2022.
0
The South Korean market acquired a 7.2% share of the Asia-Pacific pharmaceuticals market in 2022. South Korea's pharmaceutical market is expected to remain strong despite concerns about a lag in drug approvals. The government's support for the industry, as seen in recent legislation, enhanced its long-term potential.

Scope

Save time carrying out entry-level research by identifying the size, growth, major segments, and leading players in the pharmaceuticals market in South Korea
Use the Five Forces analysis to determine the competitive intensity and therefore attractiveness of the pharmaceuticals market in South Korea
Leading company profiles reveal details of key pharmaceuticals market players’ global operations and financial performance
Add weight to presentations and pitches by understanding the future growth prospects of the South Korea pharmaceuticals market with five year forecasts

Reasons to Buy

What was the size of the South Korea pharmaceuticals market by value in 2022?
What will be the size of the South Korea pharmaceuticals market in 2027?
What factors are affecting the strength of competition in the South Korea pharmaceuticals market?
How has the market performed over the last five years?
What are the main segments that make up South Korea's pharmaceuticals market?

1 Executive Summary

1.1. Market value
1.2. Market value forecast
1.3. Geography segmentation
1.4. Market rivalry
1.5. Competitive landscape

2 Market Overview

2.1. Market definition
2.2. Market analysis

3 Market Data

3.1. Market value

4 Market Segmentation

4.1. Geography segmentation

5 Market Outlook

5.1. Market value forecast

6 Five Forces Analysis

6.1. Summary
6.2. Buyer power
6.3. Supplier power
6.4. New entrants
6.5. Threat of substitutes
6.6. Degree of rivalry

7 Competitive Landscape

7.1. Who are the leading players?
7.2. What strategies do leading players follow?
7.3. What are the most recent market developments?

8 Company Profiles

8.1. Chong Kun Dang Pharmaceutical Corp.
8.2. Daewoong Pharmaceutical Co Ltd
8.3. Hanmi Pharmaceuticals Co Ltd
8.4. Pfizer Inc.

9 Macroeconomic Indicators

9.1. Country data

10 Appendix

10.1. Methodology
10.2. Industry associations
10.3. Related research
10.4. About the Publisher

List of Tables

Table 1: South Korea pharmaceuticals market value: $ billion, 2017-22
Table 2: South Korea pharmaceuticals market geography segmentation: $ billion, 2022
Table 3: South Korea pharmaceuticals market value forecast: $ billion, 2022-27
Table 4: Chong Kun Dang Pharmaceutical Corp.: key facts
Table 5: Chong Kun Dang Pharmaceutical Corp.: Annual Financial Ratios
Table 6: Chong Kun Dang Pharmaceutical Corp.: Key Employees
Table 7: Daewoong Pharmaceutical Co Ltd: key facts
Table 8: Daewoong Pharmaceutical Co Ltd: Annual Financial Ratios
Table 9: Daewoong Pharmaceutical Co Ltd: Key Employees
Table 10: Hanmi Pharmaceuticals Co Ltd: key facts
Table 11: Hanmi Pharmaceuticals Co Ltd: Annual Financial Ratios
Table 12: Hanmi Pharmaceuticals Co Ltd: Key Employees
Table 13: Pfizer Inc.: key facts
Table 14: Pfizer Inc.: Annual Financial Ratios
Table 15: Pfizer Inc.: Key Employees
Table 16: Pfizer Inc.: Key Employees Continued
Table 17: South Korea size of population (million), 2018-22
Table 18: South Korea gdp (constant 2005 prices, $ billion), 2018-22
Table 19: South Korea gdp (current prices, $ billion), 2018-22
Table 20: South Korea inflation, 2018-22
Table 21: South Korea consumer price index (absolute), 2018-22
Table 22: South Korea exchange rate, 2018-22

List of Figures

Figure 1: South Korea pharmaceuticals market value: $ billion, 2017-22
Figure 2: South Korea pharmaceuticals market geography segmentation: % share, by value, 2022
Figure 3: South Korea pharmaceuticals market value forecast: $ billion, 2022-27
Figure 4: Forces driving competition in the pharmaceuticals market in South Korea, 2022
Figure 5: Drivers of buyer power in the pharmaceuticals market in South Korea, 2022
Figure 6: Drivers of supplier power in the pharmaceuticals market in South Korea, 2022
Figure 7: Factors influencing the likelihood of new entrants in the pharmaceuticals market in South Korea, 2022
Figure 8: Factors influencing the threat of substitutes in the pharmaceuticals market in South Korea, 2022
Figure 9: Drivers of degree of rivalry in the pharmaceuticals market in South Korea, 2022

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

Chong Kun Dang Pharmaceutical Corp.
Daewoong Pharmaceutical Co Ltd
Hanmi Pharmaceuticals Co Ltd
Pfizer Inc.

License	Format	Properties	Price
SINGLE USER LICENSE PDF	The product is a PDF.	This is a single user license, allowing one user access to the product.	€309EUR$350USD£268GBP
SITE LICENSE PDF	The product is a PDF.	This is a site license, allowing all users within a given geographical location of your organization access to the product.	€464EUR$525USD£401GBP
ENTERPRISE LICENSE PDF	The product is a PDF.	This is an enterprise license, allowing all employees within your organization access to the product.	€619EUR$700USD£535GBP

Key Highlights

Scope

Reasons to Buy

Table of Contents

Companies Mentioned (Partial List)

Related Topics

Related Reports

Pharmaceuticals in South Korea

Pharmaceuticals in Asia-Pacific

Licensing Deals in Pharmaceuticals 2020-2025

Global Big Pharma Partnering Terms and Agreements 2020-2024

Pharmaceutical Drugs Market Report 2025